Clinical Trial Update: Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia [NA]

View source ↗

Summary

Clinical trial investigating how endothelial cells with ACVRL1, ENG, or SMAD4 mutations respond to BMP9 to identify new therapeutic targets for hereditary hemor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemorrhagic Telangiectasia

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hereditary Haemorrhagic Telangiectasia | NA | Status: COMPLETED